Home
Conditions
Metastatic Gastrointestinal Carcinoid Tumor

Clinical trial condition

Metastatic Gastrointestinal Carcinoid Tumor

Explore clinical trials studying Metastatic Gastrointestinal Carcinoid Tumor. Study availability and eligibility vary by location and protocol.

11 public trials 1 recruiting study

Refine in advanced search Browse all conditions

Metastatic Gastrointestinal Carcinoid Tumor trial results

Recruiting

EMB-01 in Patients With Advanced/Metastatic Gastrointestinal Cancers

NCT05176665

Conditions: Metastatic Gastrointestinal Carcinoid Tumor, Neoplasm Metastasis, Neoplasms, +3 more
Locations: MD Anderson Cancer Center Houston, Texas, United States

Beijing cancer Hospital Beijing, Beijing Municipality, China

Nanfang Hospital Guangzhou, Guangdong, China

Hunan Cancer Hospital Changsha, China

View all 14 locations

View Trial Details

Completed

Everolimus and Vatalanib in Treating Patients With Advanced Solid Tumors

NCT00655655

Conditions: Adenocarcinoma, Adenoma, Adenoma, Islet Cell, +70 more
Locations: Mayo Clinic Rochester, Minnesota, United States

View Trial Details

Completed

Regorafenib in Treating Patients With Advanced or Metastatic Neuroendocrine Tumors

NCT02259725

Conditions: Adenocarcinoma, Adenoma, Adenoma, Islet Cell, +25 more
Locations: Mayo Clinic in Arizona Scottsdale, Arizona, United States

USC Norris Comprehensive Cancer Center Los Angeles, California, United States

Hoag Memorial Hospital Presbyterian Newport Beach, California, United States

USC Norris Oncology Hematology-Newport Beach Newport Beach, California, United States

View Trial Details

Completed

Temsirolimus in Treating Patients With Metastatic Neuroendocrine Carcinoma

NCT00093782

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Islet Cell, +14 more
Locations: Princess Margaret Hospital Phase 2 Consortium Toronto, Ontario, Canada

View Trial Details

Completed

Temsirolimus and Vinorelbine Ditartrate in Treating Patients With Unresectable or Metastatic Solid Tumors

NCT01155258

Conditions: Adenocarcinoma, Adnexal Diseases, Breast Diseases, +115 more
Locations: USC/Norris Comprehensive Cancer Center Los Angeles, California, United States

View Trial Details

Completed

Erlotinib Hydrochloride and Cetuximab in Treating Patients With Advanced Gastrointestinal Cancer, Head and Neck Cancer, Non-Small Cell Lung Cancer, or Colorectal Cancer

NCT00397384

Conditions: Adenocarcinoma, Adenocarcinoma of the Colon, Adenocarcinoma of the Rectum, +135 more
Locations: Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States

View Trial Details

Completed

Sorafenib Tosylate in Treating Patients With Progressive Metastatic Neuroendocrine Tumors

NCT00131911

Conditions: Adenocarcinoma, Adenoma, Adenoma, Islet Cell, +28 more
Locations: Mayo Clinic Rochester, Minnesota, United States

View Trial Details

Completed

7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007)

NCT00031681

Conditions: Adenocarcinoma, Adnexal Diseases, Advanced Adult Primary Liver Cancer, +182 more
Locations: University of Virginia Charlottesville, Virginia, United States

View Trial Details

Completed

Gefitinib in Treating Patients With Progressive Metastatic Neuroendocrine Tumors

NCT00075439

Conditions: Adenocarcinoma, Adenoma, Adenoma, Islet Cell, +26 more
Locations: Mayo Clinic Rochester, Minnesota, United States

View Trial Details

Completed

Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu

NCT00004074

Conditions: Adenocarcinoma, Adenocarcinoma, Follicular, Adenocarcinoma, Papillary, +257 more
Locations: Ohio State University Medical Center Columbus, Ohio, United States

View Trial Details

Metastatic Gastrointestinal Carcinoid Tumor

Metastatic Gastrointestinal Carcinoid Tumor trial results

Related conditions